Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07029490 · ClinicalTrials.gov registry record · NA

Enhancing Mammography Programs for Outreach, Wellness, Education, and Resources (EMPOWER) in Underserved Populations Study

A NA study of Breast Cancer, sponsored by University of Utah.

Recruiting
Registry status
NA
Development phase
2,700
Enrollment target
1
Study location

NCT07029490: Recruiting NA study of Breast Cancer, sponsored by University of Utah.

NCT07029490 is a NA study of Breast Cancer that is actively recruiting participants, run by University of Utah. The registered enrollment target is 2,700 participants, roughly in line with the 2,801-participant average among 1,224 other Breast Cancer trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07029490, a NA study of Breast Cancer, is actively recruiting participants, sponsored by University of Utah.

RECRUITING
Registry status
NA
Development phase
2,700 participants
Enrollment target
1
Study location

Study Summary

This study is investigating the feasibility of a digital tool called a chatbot for providing educational information about mammography through a tablet, computer, or phone. This study will recruit participants who recently had a mammogram with the University of Utah. Based on their mammography results, women will be placed into two cohorts using their BI-RADS category. Once mammogram results are available, patients will be randomized 1:1 to either usual care or usual care with chatbot. This study will randomly invite participants from four groups for focus group discussions (FGDs) based on their mammogram results and adherence to screening recommendations

Primary Outcome

This outcome measure will test the addition of virtual navigation to usual processes of care to increase screening adherence for underserved women undergoing mobile mammography who have an abnormal breast cancer screening exam. Screening adherence will be measured as a two-point survey item (Yes/No). This outcome measure will report the proportion of participants who self-reported screening adherence.

Conditions Studied

Interventions

  • OTHER Chatbot

Study Locations (1)

Utah

  • Huntsman Cancer Institute/ University of Utah - Salt Lake City

Trial Details

FieldValue
Enrollment Target 2,700 participants
Start Date 2025-11-19
Est. Completion 2028-09
Phase NA
University of Utah

818 total trials

What NCT07029490 shows while recruiting

NCT07029490 is an interventional study that assigns participants to a tested intervention. Its 2,700 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 2,801-participant average among 1,224 other Breast Cancer trials with a reported enrollment target.

The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Chatbot is the first listed.

NCT07029490 reports a single indexed study location in Utah.

Frequently Asked Questions

What is clinical trial NCT07029490 about?

NCT07029490 is a clinical study titled "Enhancing Mammography Programs for Outreach, Wellness, Education, and Resources (EMPOWER) in Underserved Populations Study". This study is investigating the feasibility of a digital tool called a chatbot for providing educational information about mammography through a tablet, computer, or phone. This study will recruit participants who recently had a mammogram with the University of Utah. Based on their mammography resul...

What is the current status of trial NCT07029490?

This trial is currently recruiting. It is a NA study. The enrollment target is 2,700 participants. The study started on 2025-11-19. Estimated completion is 2028-09.

What conditions does trial NCT07029490 study?

This clinical trial studies the following conditions: Breast Cancer.

What interventions are being tested in trial NCT07029490?

The interventions under investigation include: Chatbot (OTHER).

Who is sponsoring clinical trial NCT07029490?

This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07029490 being conducted?

This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07029490's enrollment target sits among peer trials

2,700 54th of 1224 higher than 1,171 of 1,224 other Breast Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04073420 · 2,700 participants

    Medtronic Cardiac Surgery PMCF Registry

  • NCT05125939 · 2,700 participants

    Can Overall Adenoma Detection Rate Replace Screening Adenoma Detection Rate ? Multicenter Study

  • NCT05586776 · 2,700 participants · Phase 4

    Decolonization to Reduce After-Surgery Events of Surgical Site Infection

  • NCT06052267 · 2,700 participants · Phase 3

    A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07029490, the US trial registry maintained by the National Library of Medicine. NCT07029490 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.